Cleared Traditional

K191574 - OxSAT 100

K191574 is the FDA 510(k) clearance for OxSAT 100 by S.L.P. , Ltd.. It is a Class 2 Anesthesiology device (product code DQA) cleared through the Traditional 510(k) pathway after a 300-day FDA review.

K191574 · S.L.P. , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2020
Decision
300d
Days
Class 2
Risk

K191574 is an FDA 510(k) clearance for the OxSAT 100. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by S.L.P. , Ltd. (Tel-Aviv, IL). The FDA issued a Cleared decision on April 9, 2020 after a review of 300 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all S.L.P. , Ltd. devices

Submission Details

510(k) Number K191574 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 2019
Decision Date April 09, 2020
Days to Decision 300 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
160d slower than avg
Panel avg: 140d · This submission: 300d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

S.L.P. Ltd. C/O Promedic, LLC
Paul Dryden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQA Oximeter

All 367
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K191574.
Oxxiom
K200537 · True Wearables, Inc. · Jul 2020
H500 Multi-Sensing Oximetry System
K192900 · Nonin Medical, Inc. · Jun 2020
Leadtek Fingertip Pulse Oximeter
K193350 · Leadtek Research, Inc. · Apr 2020
Disposable SpO2 Sensor
K200069 · Shenzhen Changke Connect Electronics Co., Ltd. · Mar 2020
Disposable SpO2 Sensor
K192608 · Shenzhen Sino-K Medical Technology Co.,Ltd · Jan 2020
Patient Monitor
K192343 · Shenzhen Creative Industry Co., Ltd. · Dec 2019